In Vivo Instability of <sup>177</sup>Lu-DOTATATE During Peptide Receptor Radionuclide Therapy
Mark Lubberink(Uppsala University), Anders Sundin, Ezgi Ilan(Uppsala University), Katarzyna Fröss‐Baron(Uppsala University Hospital), Amalia Öst(Uppsala University Hospital), Mattias Sandström(Uppsala University Hospital), Irina Velikyan(Uppsala University), Camilla Andersson(Uppsala University), Helena Wilking(Uppsala University Hospital)
Cited by 29
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
|Annals of Oncology|2015|698
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
|Neuroendocrinology|2017|495
A regional air quality forecasting system over Europe: the MACC-II daily ensemble production
|Geoscientific model development|2015|378